Table I.
Characteristic of patients with UTI enrolled in the study.
| Characteristic | Total UTI n = 498 (100%) | CAUTI n = 60 (100%) | non-CAUTI n = 438 (100%) | OR (95% CI) | p-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | ||||
| Gender: | Male | 179 | 35.9% | 37 | 61.7% | 142 | 32.4% | 3.35 (1.92–5.86) | < 0.001 |
| Female | 319 | 64.1% | 23 | 38.3% | 296 | 67.6% | 0.30 (0.17–0.52) | < 0.001 | |
| Hypertension | 263 | 52.8% | 37 | 61.7% | 226 | 51.6% | 1.51 (0.87–2.62) | 0.145 | |
| Heart failure | 174 | 34.9% | 23 | 38.3% | 141 | 32.2% | 1.31 (0.75–2.29) | 0.344 | |
| Diabetes mellitus | 190 | 38.2% | 18 | 30.0% | 172 | 39.3% | 0.72 (0.40–1.28) | 0.258 | |
| Urolithiasis | 22 | 4.4% | 1 | 1.7% | 21 | 4.8% | 0.34 (0.04–2.55) | 0.292 | |
| Bronchopneumonia | 9 | 1.8% | 1 | 1.7% | 8 | 1.8% | 0.91 (0.11–7.41) | 0.931 | |
| Malignancy (total) | 80 | 16.1% | 11 | 18.3% | 69 | 15.8% | 1.34 (0.68–2.65) | 0.405 | |
| Genitourinary malignancy | 41 | 8.2% | 9 | 15.0% | 32 | 7.3% | 2.24 (1.01–4.96) | 0.047 | |
| Prostatic hyperplasia | 57 | 11.4% | 10 | 16.7% | 47 | 10.7% | 1.66 (0.79–3.50) | 0.180 | |
| Urine stasis in kidneys | 23 | 4.6% | 5 | 8.3% | 18 | 4.1% | 4.34 (1.76–10.73) | 0.001 | |
| Percutaneous nephrostomy | 8 | 1.6% | 1 | 1.7% | 7 | 1.6 % | 1.04 (0.13–8.63) | 0.968 | |
| Hemodialysis | 20 | 4.0% | 2 | 3.3% | 18 | 4.1% | 0.80 (0.18–3.56) | 0.774 | |
| Immunotherapy | 26 | 5.2% | 4 | 6.7% | 22 | 5.0% | 1.35 (0.45–4.06) | 0.593 | |
Data are expressed as number and percentage.
One patient may have several co-existing diseases